| Title of Invention | PHARMACEUTICAL COMBINATIONS |
|---|---|
| Abstract | N/A |
| Full Text |
|---|
1025-MUMNP-2003-ABSTRACT(AMENDED)-(11-7-2007).pdf
1025-mumnp-2003-abstract(granted)-(18-6-2009).pdf
1025-MUMNP-2003-CANCELLED PAGES(20-2-2008).pdf
1025-MUMNP-2003-CLAIMS(7-11-2003).pdf
1025-MUMNP-2003-CLAIMS(AMENDED)-(11-7-2007).pdf
1025-MUMNP-2003-CLAIMS(AMENDED)-(23-7-2007).pdf
1025-mumnp-2003-claims(granted)-(18-6-2009).pdf
1025-MUMNP-2003-CORRESPONDENCE(2-6-2009).pdf
1025-MUMNP-2003-CORRESPONDENCE(IPO)-(2-7-2009).pdf
1025-MUMNP-2003-DESCRIPTION(COMPLETE)-(7-11-2003).pdf
1025-mumnp-2003-description(granted)-(18-6-2009).pdf
1025-MUMNP-2003-FORM 1(11-7-2007).pdf
1025-MUMNP-2003-FORM 1(7-11-2003).pdf
1025-MUMNP-2003-FORM 13(12-7-2007).pdf
1025-mumnp-2003-form 13(2-6-2009).pdf
1025-MUMNP-2003-FORM 19(7-11-2003).pdf
1025-MUMNP-2003-FORM 2(COMPLETE)-(7-11-2003).pdf
1025-mumnp-2003-form 2(granted)-(18-6-2009).pdf
1025-MUMNP-2003-FORM 2(TITLE PAGE)-(7-11-2003).pdf
1025-mumnp-2003-form 2(title page)-(granted)-(18-6-2009).pdf
1025-MUMNP-2003-FORM 3(11-7-2007).pdf
1025-MUMNP-2003-FORM 3(3-12-2003).pdf
1025-MUMNP-2003-FORM 3(7-11-2003).pdf
1025-MUMNP-2003-FORM 5(7-11-2003).pdf
1025-MUMNP-2003-PETITION UNDER RULE 137(12-7-2007).pdf
1025-MUMNP-2003-PETITION UNDER RULE 138(12-7-2007).pdf
1025-MUMNP-2003-POWER OF AUTHORITY(11-7-2007).pdf
1025-MUMNP-2003-POWER OF AUTHORITY(5-3-2004).pdf
| Patent Number | 234874 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Indian Patent Application Number | 1025/MUMNP/2003 | |||||||||
| PG Journal Number | 28/2009 | |||||||||
| Publication Date | 10-Jul-2009 | |||||||||
| Grant Date | 18-Jun-2009 | |||||||||
| Date of Filing | 07-Nov-2003 | |||||||||
| Name of Patentee | ASTRAZENECA AB | |||||||||
| Applicant Address | S-15185 SODERTALJE. | |||||||||
Inventors:
|
||||||||||
| PCT International Classification Number | A61K31/519 | |||||||||
| PCT International Application Number | PCT/SE02/01033 | |||||||||
| PCT International Filing date | 2002-05-29 | |||||||||
PCT Conventions:
|
||||||||||